LG Life Sciences' business started in earnest with the development of Eutropin, a human growth hormone in 1993 and completion of the Iksan Pharmaceutical Plant. In October 2002 LG Life Sciences spun off from LG Chem Investment. LG Life Sciences plans to focus its R&D on the development of new anti-infective and anti-cancer drugs. Its other divisions will make efforts for the maximization of synergistic effects through business alliances with other world-class business enterprises specializing in musculoskeletal, cardiovascular and endocrine systems and metabolism. The company also seeks to enhance its competitiveness through bolstered marketing activities and bio engineering products like human growth hormone and interferon.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
LG Life Sciences
LG Twin Tower
East Tower
20, Yoido-dong
Seoul South Korea
All rights reserved. Terms and Conditions | Contact us
